Company · CIK 2058707
Attovia Therapeutics, Inc.
| CIK | 2058707 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | ATTO (Nasdaq) |
| First annual or quarterly report | 2026-09-02 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-297452 | 2026-07-14 | 2026-08-05 | 5 |
Filings
6| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-05 | 424B4Final prospectus | 333-297452 | 0001193125-26-334997 |
| 2026-08-04 | EFFECTDeclared effective | 333-297452 | 9999999995-26-002535 |
| 2026-08-04 | S-1/AAmendment | 333-297452 | 0001193125-26-331510 |
| 2026-07-29 | S-1/AAmendment | 333-297452 | 0001193125-26-323618 |
| 2026-07-14 | S-1Registration filed | 333-297452 | 0001193125-26-303256 |
| 2025-12-19 | DRSDraft made public | 377-08845 | 0001193125-25-326945 |